Electronic Health Records

News Article

Nephrology Journal Club

Wednesday 26th April’s Nephrology Journal Club is going to be based on a recent paper written by members of out group. Laurie Tomlinson has...

Wednesday, 26 April 2017
Blog Post

Report from 1st EDEN Forum

By Anna Ascott School researcher, Dr Sinéad Langan helped organise the first European Dermatology Epidemiology Network (EDEN) Forum, which was held on 30-31 March 2017, in Madrid, Spain  Dermato-Epidemiology, which describes the study of causes, prevention, health services research and evaluation of interventions of skin diseases, is particularly important for dermatology, as a relatively...

Monday, 24 April 2017
Blog Post

Blog – Availability of clinical trial data for research purposes

By Kevin Wing. I recently attended a session entitled EMA’s Policy on Clinical Publication: Opportunities, Challenges and Measuring Success at the Drug Information Association annual conference in Glasgow, (still just about) UK, focusing on progress of the European Medicines Agency’s (EMA) new policy for making complete clinical trial data available for access by the public and researchers...

Wednesday, 19 April 2017
Blog Post

PHE Conference and ISPE mid-year meeting

by Andreia Leite. Members of the electronic health records (EHR) group have recently attended two conferences:  Public Health England (PHE) Research and Applied Epidemiology Scientific Conference 2017 and ISPE 2017 mid-year meeting. In both, researchers from the group presented work using data from the Clinical Practice Research Datalink (CPRD). PHE conference joined professionals working in...

Monday, 10 April 2017
News Article

Even small reductions in kidney function after starting common blood pressure drugs are associated with increased risk

Angiotensin converting enzyme inhibitors (ACEI) (drugs with names ending in –pril, e.g. enalapril) and angiotensin receptor blockers (ARB) (drugs with names ending in –sartan, e.g. losartan) are drugs that are commonly used to treat high blood pressure and heart failure. Current guidelines recommend that they should be stopped in people who have a reduction in kidney function (measured using...

Monday, 3 April 2017
News Article

New NIHR-funded post to study drug-treatment effects using observational data

Dr Kevin Wing has taken up a 3-year NIHR-funded position to study the effectiveness of drugs for Chronic Obstructive Pulmonary Disease (COPD) within observational data. Using randomised controlled trial individual patient data from clinicalstudydatarequest.com and observational data from the Clinical Practice Research Datalink (CPRD), optimal methods for assessing COPD treatment effectiveness in...

Thursday, 30 March 2017
News Article

How useful are observational data for drug regulatory decision making?

We have just been awarded a grant by the Association of the British Pharmaceutical Industry to determine how observational research using electronic...

Thursday, 9 March 2017
News Article

StatinWISE trial testimonial

“StatinWISE will answer a really important question: whether the muscular aches and pains that lots of people have are actually caused by...

Thursday, 23 February 2017
News Article

New 100 million cohort in Brazil

Working in partnership with Brazilian researchers, we have helped secure Wellcome funding to develop a new biomedical resource: the 100 million...

Wednesday, 22 February 2017
News Article

StatinWISE now recruiting!

StatinWISE is a trial designed to find out whether the muscle symptoms experienced during statin use are caused by statins.  Statins are the most...

Friday, 3 February 2017
Blog Post

Comorbidites in patients with chronic kidney disease – Masao Iwagami

In August 2016, our monthly Journal Club featured a Nephrology article entitled “Comorbidity as a driver of adverse outcomes in people with chronic...

Tuesday, 27 September 2016